The policy gradually opens up the prospect of replacing traditional pieces of Decoction with traditional Chinese medicine formula granules

[market analysis of chinapharma.com] recently, China food and Drug Administration issued Quality Inspection Notice No 59: 33 batches of Chinese herbal pieces are unqualified This is the fifth time that the quality of Chinese herbal pieces has been announced by China food and drug administration since this year, and the number of batches disclosed has reached 168, which highlights that the quality of Chinese Herbal Pieces industry is seriously unqualified at present (the policy is gradually opening up the prospect of replacing traditional pieces of Chinese medicine with formula granules Photo source: Baidu photo) Chinese medicine pieces have been repeatedly listed in the black list of quality inspection According to the special sampling test of Chinese medicine and pieces of Chinese medicine organized by the food and Drug Administration in early 2017, the main problems of Chinese medicine pieces of Chinese medicine industry at present include: 1 Serious dyeing problems In the special spot check, 87 batches of safflower were found to be acid red 73, carmine, lemon yellow, golden orange II or sunset yellow; 7 batches of Schisandra were found to be carmine or acid red 73; 3 batches of Phellodendron were found to be gold amine o; 6 batches of Coptis were found to be gold amine o; 28 batches of Corydalis were found to be gold amine o; 9 batches of cinnabar were found to be 808 scarlet 2 In the special spot check for adulteration and weight gain, rosin was detected in 12 batches of aloe; rosin acid was detected in 17 batches without drugs; rosin acid was detected in 11 batches of frankincense In addition, 4 batches of Platycodon grandiflorum had weight gain problems From the perspective of industrial chain, the quality standards of Chinese herbal pieces need to be standardized From the perspective of industrial chain, Chinese herbal pieces are in the middle of the industrial chain of Chinese herbal medicine industry, which plays an important role in the development of Chinese herbal medicine industry Under the premise of continuous development of traditional Chinese medicine industry, the processing industry of Chinese herbal pieces has also achieved rapid development According to the data of the report on the processing industry of Chinese herbal pieces from prospective industry research institute, however, as mentioned above, the quality problems of Chinese Herbal Pieces industry are still prominent, which seriously affects the healthy development of Chinese herbal medicine industry According to the prospective industry research institute, the main reasons for the prominent quality problems of Chinese herbal pieces include: 1 The lack of industry standard is based on the statistics of prospective industry research institute Up to now, there are only 8 relevant standards issued by Chinese Herbal Pieces processing industry, 3 of which are invalid, and only 5 in the industry 2 It is difficult to control the source quality of raw materials of Chinese herbal pieces At present, the standardization and standardization in the process of planting and breeding of Chinese herbal pieces are not in place, such as the abuse of chemical fertilizers and pesticides leading to the residue of harmful substances; the nonstandard operation in the primary processing of the origin leading to the poor quality of Chinese herbal pieces; the non genuine planting leading to the difference of drug properties of Chinese herbal pieces, etc., will lead to the unqualified quality of Chinese herbal pieces The policy is gradually open, and the prospect of traditional Chinese medicine granules replacing traditional pieces of decoction is promising On the one hand, the quality of traditional Chinese medicine pieces of decoction is seriously unqualified On the other hand, the policy of traditional Chinese medicine granules is open The author thinks that the substitution threat of traditional Chinese medicine pieces of Decoction in the future is relatively large As a new type of Chinese herbal pieces, Chinese herbal formula granules have a certain substitution for traditional Chinese herbal pieces According to the report data released by the prospective industry research institute, at present, the market scale of Chinese herbal formula granules in China is still small, accounting for about 5.05% of Chinese herbal pieces In contrast, at present, in Taiwan, Hong Kong, Japan and other regions, the proportion of Chinese herbal formula granules in clinical substitution for Chinese herbal pieces has exceeded 60% After more than 10 years of trial implementation, China's management of traditional Chinese medicine formula granules has shown a trend of opening up (in 2015, the state issued the measures for the management of traditional Chinese medicine formula granules (Draft for comments), and in March 2016, it announced the end of public consultation) Prospective Industry Research Institute believes that in the future, with the opening of policies, the increase of market participants, as well as for traditional Chinese medicine Pieces With the replacement of the market, Chinese herbal formula granules will have a rapid development, and the market scale is expected to reach about 60 billion yuan by 2022.